J.P. Morgan Day One: Biopharma Braces For Headwinds Ahead

 
• By Scrip Team

Daily notebook from the J.P. Morgan Healthcare Conference: Turbulent weather matches sentiment about the year ahead, with investors looking for reassurance on the IRA, deal-making and growth strategy from big pharma. Updates from J&J, Biogen, BMS, Merck and more.

J.P. Morgan Daily Notebook: Day 1
• Source: Shutterstock

More from Strategy

More from Business